FLSM
Frazier Life Sciences Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-397,483
| Closed | -$14.1M | – | 52 |
|
|
2023
Q4 | $14.1M | Sell |
397,483
-1,192,448
| -75% | -$42.4M | 0.76% | 36 |
|
|
2023
Q3 | $47.3M | Buy |
1,589,931
+175,108
| +12% | +$5.21M | 3.14% | 10 |
|
|
2023
Q2 | $25.5M | Hold |
1,414,823
| – | – | 1.52% | 17 |
|
|
2023
Q1 | $22.7M | Hold |
1,414,823
| – | – | 1.65% | 16 |
|
|
2022
Q4 | $25.9M | Hold |
1,414,823
| – | – | 1.61% | 16 |
|
|
2022
Q3 | $27.8M | Hold |
1,414,823
| – | – | 2.14% | 14 |
|
|
2022
Q2 | $26.4M | Hold |
1,414,823
| – | – | 2.49% | 11 |
|
|
2022
Q1 | $31.1M | Buy |
+1,414,823
| New | +$31.1M | 2.65% | 13 |
|